• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Molift Smart 150

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
 Class 2 Device Recall Molift Smart 150 see related information
Date Posted May 21, 2013
Recall Status1 Terminated on July 11, 2014
Recall Number Z-1343-2013
Recall Event ID 64512
Product Classification Lift, patient, non-ac-powered - Product Code FSA
Product Molift Smart 150

Code Information Art #: 0920008; Serial Number range 20941 to 27299.
Recalling Firm/
Moller Vital
Hadelandsvegan 2,
P.o. Box 408
Gjovik Norway
Manufacturer Reason
for Recall
The leg spreading mechanism will fail to hoist and collapse if assemble incorrectly by the user.
FDA Determined
Cause 2
Employee error
Action Molift Group AS issued a Field Safety Notice letter to all affected customers. The letter identified the affected products, problem and actions to be taken to the Smart hoists that are already in use. Customers were instructed to make sure that all affected customers receive this information and encorage to increase attention until the affected product has been upgraded. For questions contact your local Molift representative or Customer Service at: groupsales@molift.com.
Quantity in Commerce Subject to recall 1,460 units; US: 175 units; Foreign: 1,285 units
Distribution US Nationwide Distribution: CA, FL, GA, ID, IL, KY, MA, ME, MI, MN, NC, NH, NJ, NM, NV, NY, OH, OK, PA, TN, TX, VT, WA and Hawaii. Foreign Distribution:: Australia, Austria; Belgium, Denmark, Finland, France, Germany, Iceland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Spain, Sverige, Switzerland, United Kingdom.
Total Product Life Cycle TPLC Device Report

1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.